Research summary

Probiotics and Immune Health

Quick answer

Meta-analyses of randomized placebo-controlled trials suggest orally ingested probiotics may modestly reduce the risk, duration, and severity of respiratory tract infections in nonelderly adults, but effect sizes are small, results vary by population, and the optimal regimen is not established.[1], [2]

Limitations of the evidence

The pooled effects on respiratory tract infections are small, and the benefit seen in general adult populations was not reproduced in physically active groups, indicating the response varies by population and likely by the specific product and delivery format used.[1]

Because most underlying trials carried some risk of bias and used differing strains and doses, and because the optimal regimen is undefined, these results should not be treated as a guarantee of protection or as medical advice.[1], [2]

What does the evidence support?

Read each finding with its qualification. These are source-supported statements, not a ranking of products or personal treatment advice.

Key findings, with their original qualifications and references
Finding and qualificationReferences
In a meta-analysis of randomized placebo-controlled trials in nonelderly adults, orally ingested probiotics taken for at least one week modestly lowered the risk of experiencing at least one respiratory tract infection compared with placebo. Based on randomized trials in adults aged 18-65 using orally ingested probiotics for at least 1 week; the reduction was modest (relative risk 0.91) and most included studies carried some risk of bias. The studied dose was Any dose of orally ingested probiotic for at least 1 week (doses varied across included trials).[1]
Across the same meta-analysis, probiotics were associated with modest reductions in the duration and severity of respiratory tract infections relative to placebo, though benefits were not seen in physically active populations. Effect sizes were small (Hedges' g around -0.23 for duration and -0.16 for severity) using orally ingested probiotics for at least 1 week; no benefit was observed in physically active populations. The studied dose was Any dose of orally ingested probiotic for at least 1 week (doses varied across included trials).[1]
Evidence for probiotics and immune health remains limited and the optimal dose, composition, timing, and duration of supplementation have not been established. Drawn from meta-analyses whose authors rated most included studies as having some risk-of-bias concerns and called for larger trials; findings vary by population and delivery format.[1], [2]

What the trials measured

The most directly relevant evidence comes from a systematic review and meta-analysis of 42 randomized, placebo-controlled studies in adults aged 18 to 65 (about 9,000 participants combined). In that pooled analysis, people taking orally ingested probiotics for at least one week had a modestly lower risk of experiencing at least one respiratory tract infection than those taking placebo.[1]

The same analysis also reported small reductions in how long respiratory tract infections lasted and how severe they were, again compared with placebo. Notably, these benefits were not observed in physically active populations, which suggests the effect is not uniform across all groups.[1]

Athletes and immune markers

A separate meta-analysis of randomized controlled trials in elite athletes adds nuance. It did not find a change in the number or duration of upper respiratory tract infection episodes, but it did report a reduction in the total symptom severity score and lower levels of certain inflammatory markers after probiotic supplementation. This mixed picture reinforces that any immune-related effect appears modest and context-dependent.[1], [2]

How to weigh the evidence

Across these meta-analyses, the authors rated most included studies as having some risk-of-bias concerns and called for larger trials. The optimal dose, strain composition, timing, and duration of probiotic supplementation for immune support have not been established, so current findings are best read as promising but limited rather than definitive.[1], [2]

References

  1. Orally Ingested Probiotics, Prebiotics, and Synbiotics as Countermeasures for Respiratory Tract Infections in Nonelderly Adults: A Systematic Review and Meta-Analysis.. Advances in nutrition (Bethesda, Md.). 2022. Systematic review and meta-analysis View source →
  2. Probiotic Supplementation and Respiratory Infection and Immune Function in Athletes: Systematic Review and Meta-Analysis of Randomized Controlled Trials.. Journal of athletic training. 2021. Systematic review and meta-analysis View source →

Frequently asked questions

Probiotics and Immune Health — article outline
Original editorial diagram of this page’s topics; no product photograph or clinical finding is depicted.